On Tuesday, Dynavax Technologies Corp. (NASDAQ: DVAX) was -1.71% down from the session before settling in for the closing price of $11.69. A 52-week range for DVAX has been $10.06 – $15.15.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 239.63% over the past five years. When this article was written, the company’s average yearly earnings per share was at 615.60%. With a float of $130.22 million, this company’s outstanding shares have now reached $130.62 million.
Let’s look at the performance matrix of the company that is accounted for 408 employees.
Dynavax Technologies Corp. (DVAX) Insider and Institutional Ownership
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Dynavax Technologies Corp. stocks. The insider ownership of Dynavax Technologies Corp. is 0.30%, while institutional ownership is 96.90%. The most recent insider transaction that took place on Mar 01 ’24, was worth 262,322. In this transaction Chief Accounting Officer of this company sold 20,526 shares at a rate of $12.78, taking the stock ownership to the 0 shares. Before that another transaction happened on Jan 04 ’24, when Company’s SVP and CMO sold 1,500 for $15.00, making the entire transaction worth $22,500. This insider now owns 49,925 shares in total.
Dynavax Technologies Corp. (DVAX) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around 615.60% per share during the next fiscal year.
Dynavax Technologies Corp. (NASDAQ: DVAX) Trading Performance Indicators
You can see what Dynavax Technologies Corp. (DVAX) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 12.96. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 6.46. Likewise, its price to free cash flow for the trailing twelve months is 15.56.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.07, a number that is poised to hit -0.02 in the next quarter and is forecasted to reach 0.45 in one year’s time.
Technical Analysis of Dynavax Technologies Corp. (DVAX)
Dynavax Technologies Corp. (NASDAQ: DVAX) saw its 5-day average volume 1.77 million, a negative change from its year-to-date volume of 1.94 million. As of the previous 9 days, the stock’s Stochastic %D was 9.88%. Additionally, its Average True Range was 0.28.
During the past 100 days, Dynavax Technologies Corp.’s (DVAX) raw stochastic average was set at 0.56%, which indicates a significant decrease from 1.67% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 14.25% in the past 14 days, which was lower than the 26.14% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $12.43, while its 200-day Moving Average is $13.57. Nevertheless, the first resistance level for the watch stands at $11.58 in the near term. At $11.68, the stock is likely to face the second major resistance level. The third major resistance level sits at $11.73. If the price goes on to break the first support level at $11.43, it is likely to go to the next support level at $11.38. The third support level lies at $11.28 if the price breaches the second support level.
Dynavax Technologies Corp. (NASDAQ: DVAX) Key Stats
There are 130,863K outstanding shares of the company, which has a market capitalization of 1.50 billion. As of now, sales total 232,280 K while income totals -6,390 K. Its latest quarter income was 55,600 K while its last quarter net income were 220 K.
